Trials / Completed
CompletedNCT03615781
Two Versus Four Weeks of Antibiotic Treatment in Native Joint Arthritis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 85 (actual)
- Sponsor
- University Hospital, Geneva · Academic / Other
- Sex
- All
- Age
- 18 Years – 120 Years
- Healthy volunteers
- Not accepted
Summary
The optimal duration of systemic antibiotic administration for native joint septic arthritis is unknown. The investigators perform a randomized study allowing up to 3 surgical lavages and allocating patients into a two-week's and a four week's randomization arm
Detailed description
The optimal duration of systemic antibiotic administration for native joint septic arthritis is unknown. The investigators perform a randomized study allocating patients into a two-week's and a four week's randomization arm. The adult patients are hospitalized for septic arthritis. A computer program randomizes 1:1 between a two week's and a four week's arm of targeted antibiotic treatment of which at least the first week is intravenously. The randomization may occur until Day 5 of admission. Up to three surgical interventions are allowed. The investigators allow the inclusion of all bacterial arthritis and all joints.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Two week's arm - surgery | The investigators perform a surgical drainage of the infection along with the complete removal of the infected orthopedic implant. |
| PROCEDURE | Four week's arm - surgery | The investigators perform a surgical drainage of the infection along with the complete removal of the infected orthopedic implant. |
| DRUG | Two week's arm - drugs | After the surgical implant removal, the investigators prescribe a total of 2 weeks of systemic targeted antibiotic therapy against the causative pathogen(s), of which one week is recommended to be intravenously. |
| DRUG | Four week's arm - drugs | After the surgical implant removal, the investigators prescribe a total of 4 weeks of systemic targeted antibiotic therapy against the causative pathogen(s), of which one week is recommended to be intravenously. |
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2018-04-01
- Completion
- 2018-05-18
- First posted
- 2018-08-06
- Last updated
- 2018-08-06
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT03615781. Inclusion in this directory is not an endorsement.